Cannabidiol potentiates hyperpolarization-activated cyclic nucleotide–gated (HCN4) channels
Journal of General Physiology · 2024
DOI: 10.1085/jgp.202313505 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of General Physiology, 2024. Verfasst von Dana A Page und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, Canada. Hauptthemen laut MEDLINE: Cannabidiol, Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels, Muscle Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, MITACS, Akseera Pharma.
Abstract (Originalsprache)
Cannabidiol (CBD), the main non-psychotropic phytocannabinoid produced by the Cannabis sativa plant, blocks a variety of cardiac ion channels. We aimed to identify whether CBD regulated the cardiac pacemaker channel or the hyperpolarization-activated cyclic nucleotide–gated channel (HCN4). HCN4 channels are important for the generation of the action potential in the sinoatrial node of the heart and increased heart rate in response to β-adrenergic stimulation. HCN4 channels were expressed in HEK 293T cells, and the effect of CBD application was examined using a whole-cell patch clamp. We found that CBD depolarized the V1/2 of activation in holo-HCN4 channels, with an EC50 of 1.6 µM, without changing the current density. CBD also sped activation kinetics by approximately threefold. CBD potentiation of HCN4 channels occurred via binding to the closed state of the channel. We found that CBD’s mechanism of action was distinct from cAMP, as CBD also potentiated apo-HCN4 channels. The addition of an exogenous PIP2 analog did not alter the ability of CBD to potentiate HCN4 channels, suggesting that CBD also acts using a unique mechanism from the known HCN4 potentiator PIP2. Lastly, to gain insight into CBD’s mechanism of action, computational modeling and targeted mutagenesis were used to predict that CBD binds to a lipid-binding pocket at the C-terminus of the voltage sensor. CBD represents the first FDA-approved drug to potentiate HCN4 channels, and our findings suggest a novel starting point for drug development targeting HCN4 channels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, Canada.
ORCID-Profile: Dana A Page, Peter C Ruben
Förderung
- Natural Sciences and Engineering Research Council of Canada
- MITACS
- Akseera Pharma
Zitieren
APA
Page, D. A., & Ruben, P. C. (2024). Cannabidiol potentiates hyperpolarization-activated cyclic nucleotide–gated (HCN4) channels. Journal of General Physiology. https://doi.org/10.1085/jgp.202313505
Vancouver
Page DA, Ruben PC. Cannabidiol potentiates hyperpolarization-activated cyclic nucleotide–gated (HCN4) channels. Journal of General Physiology. 2024. doi:10.1085/jgp.202313505
BibTeX
@article{Page2024,
author = {Page, Dana A and Ruben, Peter C},
title = {Cannabidiol potentiates hyperpolarization-activated cyclic nucleotide–gated (HCN4) channels},
journal = {Journal of General Physiology},
year = {2024},
doi = {10.1085/jgp.202313505}
}
EUVIMED